Page 18 - Program Overview News Today

Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA® in Recurrent/Metastatic Head and Neck Squamous Cell...

15.08.2022 - Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Phase 2 SIGNAL-HD Study Published in Nature Medicine Patient enrollment continues in ...

Connecting Communities through the History of Inspired Canadians

/PRNewswire/ -- WHAT: The Institute of Internal Auditors (IIA) announces its International Conference - the premier annual event for internal auditors and...

VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to...

15.06.2022 - VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) - Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce results of the Phase 5 Metallurgical testing program (the “Phase 5 Program” or the ...

-- NDA filing for Nirogacestat in Desmoid Tumors, Which Will Be Reviewed Under the FDA’s Real-Time Oncology Review (RTOR) Program, Expected in Second Half...

/PRNewswire/ - Scottie Resources Corp. ("Scottie" or the "Company") (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR8) is pleased to announce plans for a 15,000 metre...

TORONTO, June 7, 2022 /PRNewswire/ -- Orvana Minerals Corp. (TSX: ORV) (the "Company" or "Orvana") is pleased to announce the recent completion of Phase I of its infill and resource-growth drilling

/PRNewswire/ - Orvana Minerals Corp. (TSX: ORV) (the "Company" or "Orvana") is pleased to announce the recent completion of Phase I of its infill and...